Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil N Bhalla

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Advances in Cancer Research|October 24, 2012
HDAC inhibitors and chaperone functionRekha Rao, Warren Fiskus, Siddhartha Ganguly, et al.
Cancer Research|November 17, 2007
Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesisNicholas T Woods, Hirohito Yamaguchi, Francis Y Lee, et al.
Blood|March 8, 2003
Regulation of 17-AAG-induced apoptosis: role of Bcl-2, Bcl-XL, and Bax downstream of 17-AAG-mediated down-regulation of Akt, Raf-1, and Src kinasesRamadevi Nimmanapalli, Erica O'Bryan, Deborah Kuhn, et al.
Seminars in Hematology|May 16, 2002
Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxideMichael E O'Dwyer, Paul La Rosée, Ramedivi Nimmanapalli, et al.
Statistical Methods in Medical Research|February 28, 2025
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over timeCan Xie, Xuelin Huang, Ruosha Li, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Haematologica|October 5, 2013
Advances in myelofibrosis: a clinical case approachJohn O Mascarenhas, Attilio Orazi, Kapil N Bhalla, et al.
Blood Cancer Journal|March 23, 2021
EVI1 dysregulation: impact on biology and therapy of myeloid malignanciesChristine Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Molecular Cancer Therapeutics|May 14, 2011
Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damageKyungsoo Ha, Warren Fiskus, Rekha Rao, et al.
Cancer Research|January 26, 2002
Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cellsHirohito Yamaguchi, Shanthi R Paranawithana, Michael W Lee, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Advances in Cancer Research|October 24, 2012
HDAC inhibitors and chaperone functionRekha Rao, Warren Fiskus, Siddhartha Ganguly, et al.
Cancer Research|November 17, 2007
Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesisNicholas T Woods, Hirohito Yamaguchi, Francis Y Lee, et al.
Blood|March 8, 2003
Regulation of 17-AAG-induced apoptosis: role of Bcl-2, Bcl-XL, and Bax downstream of 17-AAG-mediated down-regulation of Akt, Raf-1, and Src kinasesRamadevi Nimmanapalli, Erica O'Bryan, Deborah Kuhn, et al.
Seminars in Hematology|May 16, 2002
Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxideMichael E O'Dwyer, Paul La Rosée, Ramedivi Nimmanapalli, et al.
Statistical Methods in Medical Research|February 28, 2025
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over timeCan Xie, Xuelin Huang, Ruosha Li, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Haematologica|October 5, 2013
Advances in myelofibrosis: a clinical case approachJohn O Mascarenhas, Attilio Orazi, Kapil N Bhalla, et al.
Blood Cancer Journal|March 23, 2021
EVI1 dysregulation: impact on biology and therapy of myeloid malignanciesChristine Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Molecular Cancer Therapeutics|May 14, 2011
Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damageKyungsoo Ha, Warren Fiskus, Rekha Rao, et al.
Cancer Research|January 26, 2002
Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cellsHirohito Yamaguchi, Shanthi R Paranawithana, Michael W Lee, et al.
Pageof 11